A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

The AACE released the 2026 update to its algorithm for the management of adults with type 2 diabetes. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, ...

A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by recommending insulin-dose ...

In addition to BP control, early and intensive management of dyslipidemia is key to preventing macrovascular complications in T2D. The AACE recommends the following lipid targets for patients with T2D ...

An algorithm paired with a continuous glucose monitor can help people living with type 2 diabetes better manage their condition by recommending insulin-dose adjustments. This is the claim of ...

Generics gain indications for glycemic control, reducing heart failure hospitalization ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency ...